65 related articles for article (PubMed ID: 37478616)
1. Clinical characteristics and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma confirmed by central pathologic review: A multi-institutional retrospective study from the Japanese Clinical Oncology Group.
Kikuchi A; Yoshida H; Tsuda H; Nishio S; Suzuki S; Takehara K; Kino N; Sumi T; Kato K; Yokoyama M; Nakamura K; Takano M; Sato S; Kato H; Tamate M; Horie K; Kato T; Sakamoto A; Fukunaga M; Kaku T; Yoshida M; Yaegashi N; Satoh T
Gynecol Oncol; 2023 Sep; 176():82-89. PubMed ID: 37478616
[TBL] [Abstract][Full Text] [Related]
2. Endometrial stromal tumors: A clinico-histomorphological spectrum of endometrial stromal tumors with review of literature.
Verma A; Tomar R; Chaturvedi A; Dhankar N; Mallya V; Khurana N
J Cancer Res Ther; 2024 Jan; 20(1):150-155. PubMed ID: 38554313
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of uterine and extrauterine low-grade endometrial stromal sarcoma: an observational cohort study.
Dai Q; Xu B; Wu H; You Y; Li L
Int J Surg; 2024 Apr; 110(4):1919-1928. PubMed ID: 38329091
[TBL] [Abstract][Full Text] [Related]
4. Targeted RNA Sequencing Highlights a Diverse Genomic and Morphologic Landscape in Low-grade Endometrial Stromal Sarcoma, Including Novel Fusion Genes.
Kolin DL; Nucci MR; Turashvili G; Song SJ; Corbett-Burns S; Cesari M; Chang MC; Clarke B; Demicco E; Dube V; Lee CH; Rouzbahman M; Shaw P; Cin PD; Swanson D; Dickson BC
Am J Surg Pathol; 2024 Jan; 48(1):36-45. PubMed ID: 37867306
[TBL] [Abstract][Full Text] [Related]
5. LG-ESSs and HG-ESSs: underlying molecular alterations and potential therapeutic strategies.
Li C; Wang C
J Zhejiang Univ Sci B; 2021 Aug; 22(8):633-646. PubMed ID: 34414699
[TBL] [Abstract][Full Text] [Related]
6. The value of surgery and the prognostic factors for patients with recurrent low-grade endometrial stromal sarcoma: a retrospective study of 38 patients.
Quan C; Zheng Z; Cao S; Wu Y; Zhang W; Huang Y
J Gynecol Oncol; 2024 Apr; ():. PubMed ID: 38725236
[TBL] [Abstract][Full Text] [Related]
7. Poor Prognosis in Low-Grade Endometrial Stromal Sarcoma With Cyclin-Dependent Kinase Inhibitor 2A Homozygous Deletion: A Case Study.
Mori A; Kamijo K; Sano M; Muramoto T; Kobayashi Y
Cureus; 2024 Feb; 16(2):e54066. PubMed ID: 38481894
[TBL] [Abstract][Full Text] [Related]
8. Low grade endometrial stromal sarcoma in a premenopausal woman.
Jetley S; Rana S; Jairajpuri ZS
J Nat Sci Biol Med; 2014 Jan; 5(1):214-7. PubMed ID: 24678233
[TBL] [Abstract][Full Text] [Related]
9. [Pelvic and celiac YWHAE-NUTM2B fusion positive high-grade endometrial stromal sarcoma: report of a case].
Zhou ZD; Lei T; Shi YQ; Li Q; Chen TB
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):406-409. PubMed ID: 38556830
[TBL] [Abstract][Full Text] [Related]
10. Favorable Outcome of High-grade Endometrial Stromal Sarcoma in an Adolescent.
Hu B; Howitt BE; Cizek S; Diver E; Hiniker S; Crane J; Daldrup-Link H; Spunt SL
J Pediatr Hematol Oncol; 2024 Apr; ():. PubMed ID: 38691023
[TBL] [Abstract][Full Text] [Related]
11. Intravenous metastasis of unexpected uterine sarcoma in the context of uterine fibroids: case report and literature review.
Huang W; Zhang T; Wang H; Liu Z; Zhai P; Wang X; Wang S
Front Oncol; 2024; 14():1354032. PubMed ID: 38425345
[TBL] [Abstract][Full Text] [Related]
12. A rare case report of low-grade endometrial sarcoma: A surgical tale from Himalayas.
Ghimire S; Shrestha P; Bhandari K
Int J Surg Case Rep; 2024 Apr; 117():109544. PubMed ID: 38507940
[TBL] [Abstract][Full Text] [Related]
13. The Spectrum of Fusions Occurring in Non-Smooth Muscle Mesenchymal Uterine Tumors: A Review of the Current Knowledge.
Dundr P; Matěj R; Hojný J; Hájková N; Němejcová K; Kendall Bártů M
Arch Pathol Lab Med; 2024 Mar; ():. PubMed ID: 38484759
[TBL] [Abstract][Full Text] [Related]
14. Folate receptor alpha is widely expressed and a potential therapeutic target in uterine and ovarian carcinosarcoma.
Saito A; Nishikawa T; Yoshida H; Mizoguchi C; Kitadai R; Yamamoto K; Yazaki S; Kojima Y; Ishikawa M; Kato T; Yonemori K
Gynecol Oncol; 2023 Sep; 176():115-121. PubMed ID: 37506533
[TBL] [Abstract][Full Text] [Related]
15. Intra-racial disaggregation reveals associations between nativity and overall survival in women with endometrial cancer.
Mercadel AJ; Sanchez-Covarrubias AP; Medina HN; Pinheiro PS; Pinto A; George SHL; Schlumbrecht MP
Gynecol Oncol; 2023 Sep; 176():98-105. PubMed ID: 37480810
[TBL] [Abstract][Full Text] [Related]
16. Is minimally invasive radical surgery safe for patients with cervical cancer ≤2 cm in size? (MISAFE): Gynecologic Oncology Research Investigators coLLborAtion study (GORILLA-1003).
Kong TW; Kim J; Son JH; Lee AJ; Yang EJ; Shim SH; Kim NK; Kim Y; Suh DH; Hwang DW; Park SJ; Kim HS; Lee YY; Yoo JG; Lee SJ; Chang SJ
Gynecol Oncol; 2023 Sep; 176():122-129. PubMed ID: 37515926
[TBL] [Abstract][Full Text] [Related]
17. A preoperative nomogram incorporating CT to predict the probability of ovarian clear cell carcinoma.
Horvat N; Causa Andrieu P; Meier A; Ji X; Lakhman Y; Soslow R; Allison D; Gangai N; Rodriguez L; Kattan MW; Chi DS; Hricak H
Gynecol Oncol; 2023 Sep; 176():90-97. PubMed ID: 37478617
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological analysis of patients with molecularly confirmed stage I adult granulosa cell tumors and prediction of recurrence.
Liu Y; Chen J; Lu Z; Chang X; Wang P; Ma H; Chen X; Mo S; Lv Z; Mao X; Zong L; Yu S; Chen J
Gynecol Oncol; 2023 Sep; 176():106-114. PubMed ID: 37481922
[TBL] [Abstract][Full Text] [Related]
19. Conservative surgical approaches for small volume FIGO stage IB1 cervical cancer. Updated survival and obstetric outcomes of an expanded cohort.
Korompelis P; Rundle S; Cassar V; Ratnavelu N; Ralte A; Biliatis I; Kucukmetin A
Gynecol Oncol; 2023 Sep; 176():155-161. PubMed ID: 37542842
[TBL] [Abstract][Full Text] [Related]
20. Extensive versus focal lymphovascular invasion in squamous cell carcinoma of the cervix: A comprehensive international, multicenter, retrospective clinicopathologic study.
Praiss AM; Allison D; Tessier-Cloutier B; Flynn J; Iasonos A; Hoang L; Patrichi A; Terinte C; Pesci A; Mateoiu C; Lastra RR; Puscasiu L; Kiyokawa T; Ali-Fehmi R; Kheil M; Oliva E; Devins KM; Abu-Rustum NR; Soslow RA; Stolnicu S
Gynecol Oncol; 2023 Sep; 176():147-154. PubMed ID: 37541128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
